535 related articles for article (PubMed ID: 33964953)
1. Hypoxia-dependent drivers of melanoma progression.
D'Aguanno S; Mallone F; Marenco M; Del Bufalo D; Moramarco A
J Exp Clin Cancer Res; 2021 May; 40(1):159. PubMed ID: 33964953
[TBL] [Abstract][Full Text] [Related]
2. Expression of Antimicrobial Peptides by Uveal and Cutaneous Melanoma Cells and Investigation of Their Role in Tumor Cell Migration and Vasculogenic Mimicry.
Manarang JC; Otteson DC; McDermott AM
Curr Eye Res; 2017 Nov; 42(11):1474-1481. PubMed ID: 28910167
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of CD146 lessens uveal melanoma progression through reducing angiogenesis and vasculogenic mimicry.
Zhang R; Chen X; Chen S; Tang J; Chen F; Lin Y; Reinach PS; Yan X; Tu L; Duan H; Qu J; Hou Q
Cell Oncol (Dordr); 2022 Aug; 45(4):557-572. PubMed ID: 35716258
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of cutaneous and uveal melanoma liver metastases.
Hoefsmit EP; Rozeman EA; Van TM; Dimitriadis P; Krijgsman O; Conway JW; Pires da Silva I; van der Wal JE; Ketelaars SLC; Bresser K; Broeks A; Kerkhoven RM; Reeves JW; Warren S; Kvistborg P; Scolyer RA; Kapiteijn EW; Peeper DS; Long GV; Schumacher TNM; Blank CU
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33262254
[TBL] [Abstract][Full Text] [Related]
5. Molecular Insights and Emerging Strategies for Treatment of Metastatic Uveal Melanoma.
Mallone F; Sacchetti M; Lambiase A; Moramarco A
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32992823
[TBL] [Abstract][Full Text] [Related]
6. HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells.
Comito G; Calvani M; Giannoni E; Bianchini F; Calorini L; Torre E; Migliore C; Giordano S; Chiarugi P
Free Radic Biol Med; 2011 Aug; 51(4):893-904. PubMed ID: 21703345
[TBL] [Abstract][Full Text] [Related]
7. Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns.
Folberg R; Arbieva Z; Moses J; Hayee A; Sandal T; Kadkol S; Lin AY; Valyi-Nagy K; Setty S; Leach L; Chévez-Barrios P; Larsen P; Majumdar D; Pe'er J; Maniotis AJ
Am J Pathol; 2006 Oct; 169(4):1376-89. PubMed ID: 17003493
[TBL] [Abstract][Full Text] [Related]
8. Involvement of HIF-1 in invasion of Mum2B uveal melanoma cells.
Victor N; Ivy A; Jiang BH; Agani FH
Clin Exp Metastasis; 2006; 23(1):87-96. PubMed ID: 16826425
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma.
Hu K; Babapoor-Farrokhran S; Rodrigues M; Deshpande M; Puchner B; Kashiwabuchi F; Hassan SJ; Asnaghi L; Handa JT; Merbs S; Eberhart CG; Semenza GL; Montaner S; Sodhi A
Oncotarget; 2016 Feb; 7(7):7816-28. PubMed ID: 26761211
[TBL] [Abstract][Full Text] [Related]
10. Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma.
Massi D; Franchi A; Paglierani M; Ketabchi S; Borgognoni L; Reali UM; Santucci M
Hum Pathol; 2004 Apr; 35(4):496-502. PubMed ID: 15116332
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Alterations and Therapeutic Opportunities in Rare Forms of Melanoma.
Han A; Schug ZT; Aplin AE
Trends Cancer; 2021 Aug; 7(8):671-681. PubMed ID: 34127435
[TBL] [Abstract][Full Text] [Related]
12. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma.
Hendrix MJ; Seftor EA; Hess AR; Seftor RE
Nat Rev Cancer; 2003 Jun; 3(6):411-21. PubMed ID: 12778131
[TBL] [Abstract][Full Text] [Related]
13. Vasculogenic mimicry and tumor angiogenesis.
Folberg R; Hendrix MJ; Maniotis AJ
Am J Pathol; 2000 Feb; 156(2):361-81. PubMed ID: 10666364
[TBL] [Abstract][Full Text] [Related]
14. Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?
Castet F; Garcia-Mulero S; Sanz-Pamplona R; Cuellar A; Casanovas O; Caminal JM; Piulats JM
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31212986
[TBL] [Abstract][Full Text] [Related]
15. New Insights into Molecular Oncogenesis and Therapy of Uveal Melanoma.
Violanti SS; Bononi I; Gallenga CE; Martini F; Tognon M; Perri P
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31109147
[TBL] [Abstract][Full Text] [Related]
16. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance.
Dratkiewicz E; Simiczyjew A; Mazurkiewicz J; Ziętek M; Matkowski R; Nowak D
Cells; 2021 Apr; 10(4):. PubMed ID: 33918883
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia promotes uveal melanoma invasion through enhanced Notch and MAPK activation.
Asnaghi L; Lin MH; Lim KS; Lim KJ; Tripathy A; Wendeborn M; Merbs SL; Handa JT; Sodhi A; Bar EE; Eberhart CG
PLoS One; 2014; 9(8):e105372. PubMed ID: 25166211
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma.
Sun B; Zhang D; Zhang S; Zhang W; Guo H; Zhao X
Cancer Lett; 2007 May; 249(2):188-97. PubMed ID: 16997457
[TBL] [Abstract][Full Text] [Related]
20. Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicry.
Seftor RE; Seftor EA; Kirschmann DA; Hendrix MJ
Mol Cancer Ther; 2002 Nov; 1(13):1173-9. PubMed ID: 12479698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]